약 이야기] 당뇨약이 비만약으로? 유행처럼 번지는 'GLP-1 유사체'
US$ 27.38
downsides of semaglutide for Weight Loss - What You Need to Know? by LIFEFORCE Medical Weight Loss Semaglutide Side Effects: What You
Description
We make it right
Lactobacillus alleviated obesity induced by high-fat diet in mice
Glicentin-Related Pancreatic Polypeptide Inhibits Glucose-Stimulated Insulin Secretion From the Isolated Pancreas of Adult Male Rats
Sean Wharton, MD, PharmD, Medical Director of the Wharton Medical Clinic and Adjunct Professor at McMaster University in Hamilton and York University, Toronto, Canada, concluded the presentations with an independent commentary on how the OASIS 1 and PIONEER PLUS trial findings may impact the landscape of obesity treatment and type 2 diabetes management
Abstract Purpose of Review The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the literature regarding the potential role of GLP-1 receptor agonists in the treatment of IIH as well as potential pitfalls
Your GP or specialist would consider this part of the overall picture
